InvestorsHub Logo
Followers 241
Posts 12376
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Monday, 05/04/2020 12:20:36 PM

Monday, May 04, 2020 12:20:36 PM

Post# of 703867
It's probably been 40 years since I had the pleasure of taking a course from Dr. Deming, one of two America's deemed responsible for the Japanese push for constant quality improvement after WW2. One of the things he discussed was differentiating between the vital few, and the insignificant many. The vital few were things that we could control and have some influence on, the insignificant many were completely out of our control.

In concentrating on what's happening with warrants, I believe we're spending a great deal of time on the insignificant many, as regardless of what's said, it's out of our control.

Certainly I believe if only LP warrants were extended, holders of others have a good shot at taking legal action, but I believe when we get the quarterly we'll see that all were treated equally fairly, but LP had to announce what happened with her, because of her position with the company.

We really can't affect very much right now, except perhaps the way other investors who chance on what we're saying look at the stock. It's easy to criticize management, but if the trial's a success, they'll be the toast of the town. Yes, L.P. and others will make a lot of money, but so will we.

What was L.P.'s greatest skill, she kept the company alive until trial results can be seen, which was no small feat. Was she well rewarded, yes, but how many other tiny biotech's failed to go the distance, often to be bought out at a tiny fraction of what investors thought they'd be worth. She's not yet completely succeeded, but I believe we're getting close. If she pulls it off, as long as we don't sell out, we'll be well rewarded.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News